US – Data collection and research services business Schlesinger Group has launched Schlesinger Clinical Research.
Schlesinger Clinical Research will bring together all of the company’s data collection work needed for clinical research.
The new branch of the company will be based across 30 sites and will oversee the recruitment and consistent application of clinical study research protocols, and will initially focus on non-prescription drugs.
Rob Ramirez (pictured), executive vice-president Schlesinger Group, said the new company would bring “site selection, subject enrolment and study execution expertise under one partner”.
